Femme et Homme
- | Pays :
- France
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to determine the maximum tolerated duration and schedule of oral VORINOSTAT in addition to low dose cytarabine in the treatment of Intermediate-2 and High risk myelodysplastic syndromes.
Critère d'inclusion
- Myelodysplastic syndromes